EN DE
STOCK COMPARISON

BibbInstruments AB vs Abbott Laboratories: Fair Value & Quality

Both stocks run through our 21 valuation models. Here is how BibbInstruments AB (BIBB) and Abbott Laboratories (ABT) compare, as of Aug 2, 2026.

As of Aug 2, 2026, Fair Value Calculator sees Abbott Laboratories as the less overvalued of the two: BibbInstruments AB trades at SEK 0.70 versus a fair value of SEK 0.32 (-54%), while Abbott Laboratories trades at $106 versus $74.79 (-29%).
BibbInstruments AB
BIBB.ST · SEK · Real Estate
-54%
above fair value
overvalued
PriceSEK 0.70
Fair ValueSEK 0.32
Quality30/100
Abbott Laboratories
ABT · USD · Health Care
-29%
above fair value
overvalued
Price$106
Fair Value$74.79
Quality64/100

Head-to-head numbers

Green value = the better side for that row (for valuation multiples: lower = cheaper).

BibbInstruments ABAbbott Laboratories
Valuation
—P/E (TTM)27.7×
24.76×P/S (TTM)3.89×
0.31×P/B3.36×
—EV/EBITDA15.1×
—PEG1.47×
Profitability
0%Net margin14%
—Operating margin13%
-41%Return on equity12%
-24%Return on assets6%
Growth
192%Revenue growth (YoY)8%
—Avg. growth/yr (3Y)0.5%
—Avg. growth/yr (5Y)5.1%
Balance & size
—Debt / equity0.19×
$12MMarket cap$175B
weakGrowth qualityhealthy

Abbott Laboratories leads: 2 to 4 metric wins.

Dash = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

BibbInstruments ABof which business quality 33 · market factors 22 Abbott Laboratoriesof which business quality 66 · market factors 49
ProfitabilityMargins and returns on capital today
0
50
Quality GrowthAre margins and returns improving?
59
47
CashflowEarnings quality: real cash, not paper profit
10
71
Fin. StrengthBalance sheet, leverage, solvency risk
84
80
InvestmentDisciplined investing over empire-building
49
65
Low VolatilityCalm price path (market factor)
19
83
MomentumPrice trend over the last 3–12 months (market factor)
33
37
52W MomentumDistance to the 52-week high (market factor)
4
31
Net IssuanceBuybacks instead of dilution
0
84

What the models say

The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.

BibbInstruments AB

Asset-BasedSEK 0.38

1 of 1 models see the stock below the current price.

Abbott Laboratories

DCF Models$70.99
Earnings-Based$29.42
Dividend Discount$39.73
Multiples$69.29
Asset-Based$20.05
Growth DCF$67.02
Economic Profit$37.49
Growth Earnings$64.43

26 of 26 models see the stock below the current price.

Scenario ranges

From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.

BibbInstruments AB
Bear SEK 0.25Fair Value SEK 0.32Bull SEK 0.41
SEK 0.70 = current price (white tick)
Abbott Laboratories
Bear $51.84Fair Value $74.79Bull $94.43
$106 = current price (white tick)

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

BibbInstruments AB · Real Estate

Quality score30 · bottom 25%
Fair value upside-54% · bottom 25%

Abbott Laboratories · Health Care

Quality score64 · Top 25%
Fair value upside-29% · above median

Bottom line

As of Aug 2, 2026, Fair Value Calculator sees Abbott Laboratories as the less overvalued of the two: BibbInstruments AB trades at SEK 0.70 versus a fair value of SEK 0.32 (-54%), while Abbott Laboratories trades at $106 versus $74.79 (-29%).

Abbott Laboratories has the higher quality score (64/100).

See the full analysis →
BibbInstruments AB · Abbott Laboratories

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Related to BibbInstruments AB

Alphabet Inc Class C vs Verizon CommunicationsAlphabet Inc Class C vs At&tAlphabet Inc Class C vs NetEaseAmazon.com vs Toyota Motor Corporation

Related to Abbott Laboratories

Amazon.com vs PDD HoldingsAmazon.com vs Sony GroupMeta Platforms vs Verizon CommunicationsMeta Platforms vs At&t
Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.